BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Approvals
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/18/2014  More...
FDA OKs Merck & Co., Inc. (MRK) Tablet To Reduce Ragweed Allergies 4/18/2014  More...
GlaxoSmithKline (GSK) Announces Approval In Canada For Incruse™ Ellipta™ (Umeclidinium) As A Treatment For COPD 4/17/2014  More...
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014  More...
FDA Approves Merck & Co., Inc. (MRK)'s Grass Pollen Pill GRASTEK® 4/15/2014  More...
Par Pharmaceutical, Inc. Begins Shipment Of Potassium Chloride Extended-Release Capsules 4/8/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014  More...
Boehringer Ingelheim Pharmaceuticals, Inc. Release: FDA Approves Pradaxa® (Dabigatran Etexilate Mesylate) For Treatment And Reduction In The Risk Of Recurrence Of Deep Venous Thrombosis And Pulmonary Embolism 4/7/2014  More...
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014  More...
Dyax Corp. (DYAX) Receives FDA Approval To Expand Use Of KALBITOR® (Ecallantide) For The Treatment Of Acute Attacks Of Hereditary Angioedema To Patients 12 Years Of Age And Older 4/4/2014  More...
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Luxembourg 4/3/2014  More...
FDA Approves Kaleo's Hand-Held Auto-Injector To Reverse Opioid Overdose 4/3/2014  More...
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014  More...
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Hemophilia B Drug Alprolix 3/31/2014  More...
FDA OKs Janssen Pharmaceutical Inc. 's Topamax For Migraine Prevention In Adolescents 3/31/2014  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014  More...
Pfizer Inc. (PFE) Statement On FDA Approval Of Over-the-Counter Nexium® 24HR 3/31/2014  More...
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014  More...
European Commission (EC) Approves Roche (RHHBY)'s New Formulation Of Blood Cancer Drug 3/28/2014  More...
Bay Area's Exelixis, Inc. (EXEL) Gets A Boost, Wins Approval For COMETRIQ® In European Union For Treatment Of MTC 3/27/2014  More...
GlaxoSmithKline (GSK)'s Type 2 Diabetes Drug Eperzan® Wins EU Approval 3/27/2014  More...
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014  More...
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014  More...
Celgene Corporation (CELG) Wins FDA Approval For Pill To Treat Psoriatic Arthritis 3/25/2014  More...
Novartis AG (NVS) Announces FDA Approval Of Xolair® (Omalizumab) For Chronic Idiopathic Urticaria (CIU), A Form Of Chronic Hives 3/24/2014  More...
Taiho Pharmaceutical's Lonsurf® (Trifluridine And Tipiracil Hydrochloride) Tablets Approved In Japan For Treatment Of Advanced Metastatic Colorectal Cancer 3/24/2014  More...
Health Canada Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Long-Acting ALPROLIX™ Therapy For Hemophilia B 3/24/2014  More...
Otsuka Pharmaceutical Co., Ltd.'s Samsca® Approved In Japan As The World's First Drug Therapy For ADPKD, A Rare Kidney Disease 3/24/2014  More...
Medivir AB (MVRBF): Simeprevir Has Now Been Approved In Russia 3/24/2014  More...
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Brazil For Treatment Of Multiple Sclerosis 3/21/2014  More...
Health Canada Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Long-Acting ALPROLIX™ Therapy For Hemophilia B 3/21/2014  More...
Health Canada Approves Swedish Orphan Biovitrum's Alprolix™ 3/21/2014  More...
Knight Therapeutics Announces FDA Approval For Impavido® (Miltefosine) For The Treatment Of Visceral, Mucosal And Cutaneous Leishmaniasis 3/20/2014  More...
Ferring Pharmaceuticals Receives FDA Approval For The First And Only Mixed Protocol IVF Treatment -- Combines MENOPUR® (Menotropins For Injection) And BRAVELLE® (Urofollitropin For Injection, Purified) In Single Syringe 3/19/2014  More...
Pierre Fabre Obtains FDA Approval To Market Hemangeo™ For The Treatment Of Infantile Hemangioma 3/18/2014  More...
Starpharma Holdings Ltd Release: Vivagel®-Coated Condom Approved For Marketing In Japan 3/14/2014  More...
Bristol-Myers Squibb Company (BMY)/Pfizer Inc. (PFE) Release: FDA Approves Eliquis® (Apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 3/14/2014  More...
Upsher-Smith Laboratories Receives FDA Approval For Qudexy™ XR (Topiramate) Extended-Release Capsules 3/13/2014  More...
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014  More...
Mallinckrodt Pharmaceuticals (MNK) Receives FDA Approval For XARTEMIS XR (Oxycodone Hydrochloride And Acetaminophen) Extended-Release Tablets (CII) 3/12/2014  More...
Amerigen Pharmaceuticals Announces That Its ANDA For Carbidopa 25mg Tablets Has Received Final Approval From The FDA 3/12/2014  More...
Northwest Biotherapeutics (NWBO) Jumps As Germany Permits Sale Of Brain Cancer Drug 3/11/2014  More...
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) Now Approved In Over 100 Countries For Stroke Prevention In Atrial Fibrillation 3/6/2014  More...
FDA Approves Endo Pharmaceuticals (ENDP)'s Testosterone Drug AVEED™ 3/6/2014  More...
AstraZeneca PLC (AZN) Wins FDA Approval For Bydureon® Pen 3/4/2014  More...
Vectura Group plc (VEC.L): South Korean Regulatory Authority Confirm Approval Of AirFluSal® Forspiro® 2/28/2014  More...
Oasmia Wins FDA Conditional Approval For Paccal Vet In Two Canine Cancers 2/28/2014  More...
FDA Green Lights Anika Therapeutics (ANIK)'s Osteoarthritis Drug MONOVISC® Stock Surges +31.74% At 9:51AM ET On Wednesday 2/26/2014  More...
FDA Approves Bristol-Myers Squibb Company (BMY)' Drug For Rare Fat Disorder 2/26/2014  More...
Iroko Pharmaceuticals Receives FDA Approval For TIVORBEX™ 2/25/2014  More...
Pfizer Inc. (PFE) Announces FDA Approval To Include Radiographic Data On Reduction Of Progression Of Structural Joint Damage For Adults With Moderately To Severely Active Rheumatoid Arthritis In Labeling For XELJANZ® (Tofacitinib Citrate) 2/24/2014  More...
FDA Approves Vertex Pharmaceuticals (MA) (VRTX)'s KALYDECO™ (Ivacaftor) For Use In Eight Additional Mutations That Cause Cystic Fibrosis 2/24/2014  More...
Oculus Innovative Sciences, Inc. (OCLS) Receives Approval For Oral And Throat Infection Products In Mexico 2/19/2014  More...
Chelsea Therapeutics, Inc. (CHTP) Pops As FDA Finally Approves NORTHERA™ 2/19/2014  More...
FDA Approves Booming BioMarin Pharmaceutical Inc. (BMRN)'s VIMIZIM™ 2/19/2014  More...
BioDiem Ltd. (BDM.AX)'s Announcement Of Approval Of LAIV Seasonal Flu Vaccine In India 2/18/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Full FDA Approval Of SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 2/13/2014  More...
The Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Alliance Announces Once-Monthly (Pr)ABILIFY MAINTENA(™) (ARIPIPRAZOLE For Prolonged Release Injectable Suspension)1 Now Approved In Canada For The Maintenance Treatment Of Schizophrenia In Stabilized Adult Patients 2/13/2014  More...
Pharmacyclics, Inc. (PCYC)'s Imbruvica Wins Second Cancer Approval 2/13/2014  More...
Aegerion Pharmaceuticals, Inc. (AEGR)' JUXTAPID(™) (Lomitapide) Capsules Approved In Canada For The Treatment Of Homozygous Familial Hypercholesterolemia (Hofh) 2/11/2014  More...
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID™ (Lomitapide) Capsules Approved In Canada For The Treatment Of Homozygous Familial Hypercholesterolemia (Hofh) 2/10/2014  More...
Vectura Group plc (VEC.L) Release: Norwegian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 2/10/2014  More...
Genzyme Corporation (GENZ)’s Lemtrada® Approved In Mexico For Treatment Of Multiple Sclerosis 2/4/2014  More...
Merck & Co., Inc. (MRK) Announces Canadian Approval Of GRASTEK® (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet) 2/3/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Multiple Schlerosis Med TECFIDERA® Wins European Approval 2/3/2014  More...
FDA Approves Vanda Pharmaceuticals, Inc. (VNDA)'s Sleep Disorder Drug HETLIOZ™ 2/3/2014  More...
Valeant Pharmaceuticals International (VRX) Announces Approval Of Retin-A Micro® Microsphere 0.08% 1/31/2014  More...
Acella Pharmaceuticals, LLC Announces Approval And Launch Of Loutrex Topical Cream 1/31/2014  More...
Perrigo Company (PRGO) Receives FDA Final Approval For Generic Equivalent To Prandin® 1/24/2014  More...
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia 1/24/2014  More...
AstraZeneca PLC (AZN)'s Diabetes Drug Xigduo Approved In Europe 1/23/2014  More...
Apricus Biosciences (APRI)Announces National Phase Approval For Erectile Dysfunction Cream - Vitaros® In Belgium 1/23/2014  More...
Hi-Tech Pharmacal (HITK) Receives Final Approval For Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day) 1/23/2014  More...
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID® Capsules Approved In Mexico 1/20/2014  More...
FDA Approves Affymetrix (Santa Clara, California) (AFFX)'s First Of-Its-Kind Mental Disability Blood Test For Infants 1/20/2014  More...
Keryx Biopharmaceuticals (KERX) Announces Marketing Approval Of Ferric Citrate In Japan 1/17/2014  More...
Mallinckrodt Pharmaceuticals (MNK) Rises As New Drug App Is Approved By The FDA 1/17/2014  More...
Vectura Group plc (VEC.L) Hungarian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/16/2014  More...
Perrigo Company (PRGO) Announces FDA Final Approval for Generic Version of Vanos® (Fluocinonide) Cream 0.1% 1/15/2014  More...
Novartis Pharmaceuticals Canada Inc. (NVS) Receives Health Canada Approval For Ultibro ™ Breezhaler ®, A Once-Daily Dual Bronchodilator For COPD 1/14/2014  More...
Vectura Group plc (VEC.L) German Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/13/2014  More...
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY)'s New Approach Diabetes Drug, Farxiga™, Wins FDA Approval 1/10/2014  More...
GlaxoSmithKline (GSK) Gains Accelerated FDA Approval For Combination Use Of Mekinist® (Trametinib) And Tafinlar® (Dabrafenib) 1/9/2014  More...
Merck & Co., Inc. (MRK) Receives FDA Approval For ISENTRESS® (raltegravir) For Pediatric Oral Suspension 1/8/2014  More...
Celgene International Sárl (CELG) Release: ABRAXANE® Plus Gemcitabine Receives European Marketing Authorization For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 1/7/2014  More...
Lundbeck Inc. (LUN.CO) Wins EU Marketing Approval For Brintellix To Treat Adult Depression 1/3/2014  More...
Innovus Pharma Announces Start Of Its Circumserum™ Commercial Phase In Morocco With Initial Order Of 10,000 Units By Its Partner OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) 12/27/2013  More...
FDA Gives The Green Light To Novo Nordisk A/S (NVO)'s TRETTEN® For Rare Blood Clotting Disorder 12/27/2013  More...
Supernus Pharmaceuticals (SUPN) Announces FDA Approval Of Its Partner's Product, Orenitram™ 12/27/2013  More...
United Therapeutics Corporation (UTHR) Hits All-Time High As FDA OKs Lung Disease Drug; Stock Up +30.36% At Market Close (Dec. 23, 2013) 12/27/2013  More...
EU Approves Merck KGaA (MKGAF.PK)'s Erbitux For A Subtype Of Cancer 12/23/2013  More...
Actelion Ltd. (ALIOF.PK)'s New Blood Pressure Drug Get EU Nod 12/23/2013  More...
Biota Pharmaceuticals, Inc. Reports That Laninamivir Octanoate Is Approved For The Prevention Of Influenza In Japan 12/23/2013  More...
Kanghong Pharma Gains CFDA Approval For China's First Innovative MAb 12/23/2013  More...
FDA Approves New Label Indications For Bayer HealthCare (BAY)'s Advantage Multi® (Imidacloprid + Moxidectin) In The U.S. 12/20/2013  More...
Baxter International, Inc. (BAX) Completes CE Mark Approval For VIVIA Hemodialysis System In Europe 12/20/2013  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s Second Lung Drug ANORO™ ELLIPTA™ Wins FDA Approval 12/20/2013  More...
Baxter International, Inc. (BAX) Receives FDA Approval Of FEIBA [Anti-Inhibitor Coagulant Complex] For Prophylactic Treatment Of Hemophilia A&B Patients With Inhibitors 12/19/2013  More...
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Australia For Treatment Of Multiple Sclerosis 12/19/2013  More...
Vectura Group plc (VEC.L): Danish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 12/18/2013  More...
CSL Behring's Kcentra® Receives FDA Approval For Use In Warfarin Reversal In Patients Undergoing Surgery 12/16/2013  More...
FDA Approves Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet HIV-1 Regimen 12/16/2013  More...
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Canada For Treatment Of Multiple Sclerosis 12/13/2013  More...
Eli Lilly and Company (LLY) Gets A Huge Blow As FDA OKs Cymbalta Generics 12/12/2013  More...
FDA Approves Gilead Sciences, Inc. (GILD)'s Sovaldi™, A $1,000-A-Day Hepatitis C Pill 12/11/2013  More...
Zogenix, Inc. Announces FDA Approval Of 4 Mg SUMAVEL® Dosepro® (Sumatriptan Injection) Needle-Free Delivery System 12/10/2013  More...
Health Canada Approves Novartis Pharmaceuticals Canada Inc. (NVS)'s Bexsero*, The First Vaccine Available To Prevent Meningococcal Serogroup B (MenB)(1,2) 12/9/2013  More...
FDA Approves BioSpecifics Technologies Corporation (BSTC)'s First Drug Treatment For Peyronie's Disease 12/6/2013  More...
AstraZeneca PLC (AZN)'s Fluenz Tetra Gets European Marketing Grant 12/6/2013  More...
Innovus Pharma Receives Product License Approval Of Ejectdelay™ For Premature Ejaculation From Health Canada 12/6/2013  More...
European Medicines Agency Approves Once Every Two Weeks Dosing Option For CSL Behring UK Ltd's Hizentra® (Human Normal Immunoglobulin, SCIg) 12/5/2013  More...
Bioniche Life Sciences Inc. (BNC) Horse Product Approved For Sale In The U.S. 12/2/2013  More...
Fresenius Medical Care's Velphoro® (PA21) Receives FDA Approval 12/2/2013  More...
GW Pharmaceuticals Announces Sativex® Regulatory Approval In Switzerland 11/27/2013  More...
Johnson & Johnson (JNJ), Medivir AB (MVRBF) Win FDA Approval For Hepatitis C Pill OLYSIO™ 11/27/2013  More...
Mylan Inc. (MYL)-BioCon Limited (BIOCON.NS) Receive First Indian Biosimilar Regulatory Approval For Herceptin® 11/26/2013  More...
BTG plc (BTG.L) Surges As Varicose Vein Treatment Grabs FDA Approval; Stock Up +13.75% At Market Close (November 26, 2013) 11/26/2013  More...
FDA Approves Merck & Co., Inc. (MRK)'s NOXAFIL® (posaconazole) Delayed-Release Tablets 11/26/2013  More...
Janssen-Cilag International NV (JNJ)'s INVOKANA™ Wins Approval In The EU For Type 2 Diabetes Patients 11/26/2013  More...
Sorin Group Announces CE Mark Approval For The XL Version Of The Perceval™ Sutureless Aortic Valve 11/25/2013  More...
FDA Approves Bayer HealthCare (BAY), Onyx Pharmaceuticals, Inc. (ONXX)'s NEXAVAR® To Treat Type Of Thyroid Cancer 11/25/2013  More...
GlaxoSmithKline (GSK)'s Pioneering Bird Flu Vaccine Gets FFA Sciences Approval 11/25/2013  More...
Bavarian Nordic (BAVA.CO) Receives Health Canada Approval Of IMVAMUNE Smallpox Vaccine 11/22/2013  More...
EU Approves Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO)'s Once-Monthly Abilify Maintena® For Schizophrenia 11/21/2013  More...
Pfizer Inc. (PFE)’s XALKORI® Granted Regular FDA Approval 11/21/2013  More...
Health Canada Approves Genzyme Corporation (GENZ)'s AUBAGIO® (teriflunomide), A Once-Daily, Oral Treatment For Relapsing Remitting Multiple Sclerosis 11/20/2013  More...
Medivir AB (MVRBF) Release: Simeprevir Has Been Approved In Canada As A New Treatment For Hepatitis C 11/20/2013  More...
Swedish Orphan Biovitrum Receives Approval For Kineret® For Treatment Of Rare Disease CAPS 11/20/2013  More...
ImmunoGen, Inc. (IMGN) Announces Approval Of Roche (RHHBY)’s Kadcyla® In The European Union 11/20/2013  More...
Pfizer Inc. (PFE) Wins Final FDA Approval For XELJANZ® 11/19/2013  More...
EU Approval For Bayer AG (BAYN.DE)'s Prostate Cancer Drug 11/19/2013  More...
FDA Clears New Plasma Protocol Software For Fenwal Alyx® System 11/19/2013  More...
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)'s Vitekta™, To Treat HIV-1 Infection 11/18/2013  More...
GlaxoSmithKline (GSK)'s Asthma Drug Relvar Approved In Europe 11/18/2013  More...
Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC) Breakthrough Drug Wins FDA Approval 11/18/2013  More...
Bayer HealthCare (BAY) Receives Approval For Xofigo® (radium Ra 223 dichloride) Injection In Europe 11/15/2013  More...
Valeant Pharmaceuticals International (VRX) Announces U.S. Approval Of Luzu® Cream, 1% 11/15/2013  More...
FDA Approves Conceive Plus Fertility Personal Lubricant For U.S. Market Release 11/15/2013  More...
Lundbeck Canada Launches A New Treatment For A Rare Form Of Acute Leukemia: Acute Promyelocytic Leukemia 11/13/2013  More...
Bayer Receives Approval For Eylea® As New Drug To Treat Wet Age-Related Macular Degeneration Patients In Canada 11/12/2013  More...
Sunovion Pharmaceuticals Inc. Announces FDA Approval Of Aptiom® (Eslicarbazepine Acetate) As Once-Daily Adjunctive Treatment Of Partial-Onset Seizures 11/11/2013  More...
GIOTRIF® (afatinib) Approved by Health Canada as a Treatment for Patients With Metastatic Adenocarcinoma of the Lung With Activating EGFR Mutation(s) Who Are Tyrosine Kinase Inhibitor Naive 11/8/2013  More...
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013  More...
Eisai Inc. (ESALF.PK) Announces Availability of ACIPHEX® Sprinkle™ (Rabeprazole Sodium) for Treatment of GERD in Children Ages 1 to 11 11/8/2013  More...
Pfizer Inc. (PFE) Receives FDA Approval for a Prior Approval Supplement for EMBEDA® (Morphine Sulfate and Naltrexone Hydrochloride) Extended Release Capsules CII 11/5/2013  More...
Nuvolase Inc. ’s PinPointe™ FootLaser™ Receives Korean Regulatory Approval 11/5/2013  More...
Genentech (RHHBY) Grabs Breakthrough Approval for Chronic Leukemia Drug Gazyva 11/5/2013  More...
IGI Laboratories, Inc. Receives Formal FDA Approval for Site Transfer of Econazole Nitrate 11/1/2013  More...
IMPAX Laboratories, Inc. (IPXL) and TOLMAR Inc. Announce Final FDA Approval for Generic Solaraze® Gel (Diclofenac Sodium-3%) 10/30/2013  More...
Lundbeck Inc. (LUN.CO)'s Epilepsy Drug for Children SABRIL® Grabs FDA Approval 10/29/2013  More...
Zogenix, Inc. Receives FDA Approval for Zohydro™ ER (hydrocodone bitartrate) Extended-Release Capsules 10/28/2013  More...
Lupin Ltd. (LUPN.BO) Receives FDA Approval for its New Drug Application for Antara® Capsules 10/23/2013  More...
Basilea Pharmaceutica (BSLN.SW): Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia 10/23/2013  More...
Genentech (RHHBY) Gains FDA Approval for New Subcutaneous Formulation of Actemra® for Use in Adult Patients Living With Moderately to Severely Active Rheumatoid Arthritis 10/22/2013  More...
Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX™ 10/21/2013  More...
First Therapeutic Using iCeutica Inc.'s SoluMatrix™ Technology Receives FDA Approval 10/21/2013  More...
Cubist Pharmaceuticals, Inc. (CBST) Announces FDA Approval for Expanded Use of ENTEREG® 10/21/2013  More...
FDA Approves Actelion Ltd. (ALIOF.PK)'s Opsumit to Treat Pulmonary Arterial Hypertension 10/21/2013  More...
Boehringer Ingelheim Corporation's New Once-Daily Striverdi* (Olodaterol) Respimat® Gains Approval in First EU Countries 10/18/2013  More...
Novo Nordisk Canada Inc. (NVO) Release: Health Canada Approves Levemir® Flextouch® Prefilled Insulin Pen for the Treatment of Type 1 and Type 2 Diabetes 10/18/2013  More...
UCB Group (UCBJF.PK)'s Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults With Active Ankylosing Spondylitis 10/18/2013  More...
Bayer Inc. Release: Health Canada Approves a New Treatment Option for Patients With Gastrointestinal Stromal Tumours (GIST), a Rare Form of Sarcoma 10/17/2013  More...
EMD Serono Receives FDA Approval for Redesigned Fertility Pen 10/17/2013  More...
Novo Nordisk A/S (NVO)'s Novoeight Wins FDA Approval for Hemophilia A 10/16/2013  More...
Antares Pharma, Inc. (AIS) Release" OTREXUP™ (methotrexate) Injection Approved By FDA a New Treatment for Adults With Rheumatoid Arthritis, Children With Polyarticular Idiopathic Arthritis, and Adults With Psoriasis 10/14/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic TOBI® in the United States 10/14/2013  More...
FDA Approves Sanofi (France) (SAN.PA)'s Nasacort® Allergy 24HR for Over-the-Counter Use 10/11/2013  More...
FDA Approves Bayer HealthCare Pharmaceuticals (BAYA.F)'s New Class of Drug Adempas® (riociguat) Tablets to Treat Adults With PAH and Persistent, Recurrent or Inoperable CTEPH 10/9/2013  More...
Pfizer Inc. (PFE), Ligand Pharmaceuticals Inc. (LGND)'s Hot-Flash, Osteoporosis Drug Duavee Gets FDA Approval 10/7/2013  More...
Apricus Biosciences (APRI) Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros® in Germany 10/7/2013  More...
Valeant Pharmaceuticals International (VRX) Announces Approval of Jublia® for the Treatment of Onychomycosis in Canada 10/3/2013  More...
FDA Approves Genentech (RHHBY)'s First Pre-Surgical Breast Cancer Drug 10/2/2013  More...
Lundbeck Inc. (LUN.CO), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Win FDA Approval for Depression Drug 10/1/2013  More...
UCB, Inc. (UCBJF.PK)'s Cimzia® Wins FDA Approval for Psoriatic Arthritis 9/30/2013  More...
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in South Africa 9/30/2013  More...
FDA Approves New Dosing Option for CSL Behring's Hizentra® 9/30/2013  More...
CSL Behring Gains Approval to License Hizentra® in Japan for the Treatment of Primary Immunodeficiency and Secondary Immunodeficiency 9/27/2013  More...
Medivir AB (MVIRb.F)'s Simeprevir Has Been Approved in Japan for the Treatment of Genotype 1 Chronic Hepatitis C Infection 9/27/2013  More...
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)' Tybost™, a New Boosting Agent for HIV Therapy 9/26/2013  More...
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013  More...
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013  More...
Purdue Pharma L.P. Receives FDA Approval for 15 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII 9/24/2013  More...
Bayer AG (BAYN.DE) Grabs Approval for Adempas® as First Drug to Treat Rare Heart and Lung Disease 9/24/2013  More...
Janssen Biotech Inc.'s STELARA® (ustekinumab) Receives FDA Approval to Treat Active Psoriatic Arthritis 9/23/2013  More...
Perrigo Company (PRGO) Announces FDA Final Approval for Generic Version of Nitrolingual® Spray, 400 mcg/Spray 9/23/2013  More...
Abstral® , Manufactured and Packaged by Recipharm AB for Kyowa Hakko Kirin, Has Been Approved in Japan 9/23/2013  More...
Sosei Group Corporation's First in Class Once-Daily Dual Bronchodilator Ultibro® Breezhaler® (QVA149) Approved for the Treatment of COPD in Europe 9/23/2013  More...
Orexo AB Announces the Approval of Abstral® in Japan 9/20/2013  More...
Vectura Group plc (VEC.L) Release: Approval of Once-Daily Dual Bronchodilator Ultibro® Inhalation Capsules in Japan (QVA149) for the Treatment of COPD 9/20/2013  More...
Sosei Group Corporation: First in Class Once-Daily Dual Bronchodilator Ultibro Inhalation Capsules (QVA149) Approved for the Treatment of COPD in Japan 9/20/2013  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s RELVAR™ ELLIPTA™Gains Approval in Japan for the Treatment of Asthma 9/20/2013  More...
Skyepharma PLC (SKYEF) Release: Flutiform® Approved in Japan 9/20/2013  More...
Four-Strain AstraZeneca PLC (AZN) Flu Vaccine Wins EU Green Light 9/20/2013  More...
Huahai Pharma China-Approved to Produce AIDS Treatment 9/18/2013  More...
European Commission (EC) Approves Genzyme Corporation (GENZ)'s Multiple Sclerosis Treatment Lemtrada™ (alemtuzumab) 9/17/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Approval of Azacitidine for Injection 9/17/2013  More...
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s Generic Version of Roche (RHHBY)'s Xeloda 9/17/2013  More...
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) Receives Marketing Approval in Japan for All Patients With aHUS 9/13/2013  More...
Allergan Inc. (AGN)'s BOTOX® Now FDA-Approved for Treating Crow's Feet 9/12/2013  More...
Medigus (MDGS.TA) Announces Marketing Approval From the Israeli Ministry of Health (MEA) for SRS™ System for the Treatment of Gastroesophageal Reflux Disease (GERD) 9/12/2013  More...





 

//-->